Global Headquarters and Development and Manufacturing Campus
United States Manufacturing Capacity
With state-of-the-art clinical and commercial manufacturing facilities across the United States, Europe and Asia, AGC Biologics has the capacity and flexibility to meet each customer’s individual manufacturing needs. Our manufacturing facilities are multi-process, engineered for unidirectionalal flow and segregated to produce multiple products at different stages of manufacturing in multiple parts of the facility. This increases the flexibility and number of manufacturing solutions available to meet clients’ rigorous manufacturing and quality needs. Right. On Time.
Seattle Facilities
AGC Biologics operates multiple cGMP manufacturing lines and a variety of scales in our Bothell, Washington cell culture facility. The uni-flow design allows for capacity and technological flexibility, including extensive adoption of single-use systems, while ensuring compliance with current ICH guidelines required for cGMP compliance. Whatever the challenge, AGC Biologics is your solution for clinical and commercial manufacturing.
Facility Equipment and Technology
THREE MAMMALIAN CELL CULTURE PRODUCTION LINES
Line A
3000L stainless steel production bioreactor
750L stainless steel n-1 bioreactor
Dedicated cell expansion suite
Line B
3000L stainless steel production bioreactor\
750L stainless steel n-1 bioreactor
Dedicated cell expansion suite
Line C
Bioreactor 6Pack™ line — 6 x 2000L single-use production bioreactors
In operation since 2015
Production scales from 2000L to 12000L in a single run
Can be run as a single 2000L run or in groups of 2, 3, 4, or 6 2000L bioreactors simultaneously, sequentially or staggered -- to meet your clinical or commercial production needs
Dedicated cell expansion suite
Dedicated harvest suite
Expansion space on our manufacturing campus for additional Bioreactor 6PackTM lines
